However, there is interpatient variability in the IFN response among individuals with COVID-19, with severe patients exhibiting prolonged production of IFN-I in certain cases and absence of IFN-I expression in others (Lowery et al., 2021). This evidence concerns the gene IFNA1 and COVID-19.